A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT02356991 · SUSPENDED
Trial details
- NCT number
- NCT02356991
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2020-06-01
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.